Le Lézard
Classified in: Health, Science and technology, Business
Subject: RCN

Potrero Medical Announces Restructuring and Continued Operations


HAYWARD, Calif., Dec. 1, 2023 /PRNewswire/ -- Potrero Medical, Inc. ("Potrero" or the "Company") announced today that it has begun a voluntary restructuring of its finances by filing a pre-negotiated petition for relief under Chapter 11 of the U.S. Bankruptcy Code. The restructuring is expected to be completed in less than 75 days.

The Company believes that this voluntary reorganization will bolster its finances and facilitate its ongoing focus on elevating patient care. 

Keller Benvenutti Kim is serving as legal counsel to Potrero, and G2 Capital Advisors is serving as financial advisor.

Additional information about the bankruptcy case may be obtained by visiting https://cases.stretto.com/Potreromedical or by calling the case information line at 888.959.4846 (Toll-Free) or 949.749.2218 (International).

About Potrero:
Potrero Medical, Inc. is a medical device platform transforming patient care through precision fluid management and analytics that offer clinical decision support by providing precise data from the kidney. Potrero Medical was founded with a mission to improve patient care and save health systems money with the latest advances in artificial intelligence and sensors.?Potrero Medical is headquartered in?Hayward, CA.?For more information, visit?www.potreromed.com.

Media Relations
Myria Crawford
VP Marketing
Mcrawford@portreo.com

SOURCE Potrero Medical, Inc.


These press releases may also interest you

at 18:05
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 10:15
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

at 06:47
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...



News published on and distributed by: